NK cells are able to kill abnormal cells, including tumor cells and virus-infected cells, because the process activates the natural killer Group 2 member D receptor (NKG2D) (also known as killer cell lectin like receptor K1, KLRK1), which regulates the immune response mechanism of NK cells after receiving ligand signals (8). Here, KLRK1 is linked to neoplasm.